Co-Diagnostics, Inc. Releases COVID-19 Test Performance Data: Consistently Demonstrates 100% Sensitivity and 100% Specificity Across Independent Evaluations
Go back to Co-Diagnostics, Inc. Releases COVID-19 Test Performance Data: Consistently Demonstrates 100% Sensitivity and 100% Specificity Across Independent Evaluations| (NASDAQ: CODX) | Delayed: 1.15 +0.06 (5.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.09 | 52 Week High | $ | |||
| Open | $1.11 | 52 Week Low | $ | |||
| Day High | $1.15 | P/E | N/A | |||
| Day Low | $1.09 | EPS | $ | |||
| Volume | 79,743 | |||||

